VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,130,000 | -21.5% | 11,946 | -2.3% | 0.35% | -13.5% |
| Q2 2015 | $2,714,000 | -8.5% | 12,221 | -18.2% | 0.41% | -7.3% |
| Q1 2015 | $2,965,000 | +35.6% | 14,931 | -2.3% | 0.44% | +31.5% |
| Q4 2014 | $2,186,000 | +1.0% | 15,281 | -7.4% | 0.33% | -1.2% |
| Q3 2014 | $2,164,000 | -3.7% | 16,501 | -7.4% | 0.34% | -5.3% |
| Q2 2014 | $2,248,000 | -12.0% | 17,826 | -8.0% | 0.36% | -17.2% |
| Q1 2014 | $2,555,000 | +15.6% | 19,385 | +2.9% | 0.43% | +12.0% |
| Q4 2013 | $2,211,000 | +6.8% | 18,840 | -5.1% | 0.38% | -1.8% |
| Q3 2013 | $2,070,000 | +21.9% | 19,850 | +0.6% | 0.39% | +13.0% |
| Q2 2013 | $1,698,000 | – | 19,730 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |